It’s in this spirit that we joined legacy PolyOne and the Clariant Color business, two complementary businesses, and formed a new one that we’ve named Avient. As one, we are better positioned than ever before to lead and to make a positive difference. FX) 2022 GROWTH PROJECTIONS 23 $3.05 $3.50 2021 2022E Full Year – Adjusted EPS + 15% (+ 17% excluding FX) $0.89 $0.95 2021 2022E Q1 – Adjusted EPS + 7% (+ 10% excluding FX) ($ millions) Q1 Full Year Q1 Full Year 2021 - Actual 1,162$ 4,819$ 123$ 429$ Sustainable Solutions 27 110 12 44 Healthcare 15 66 4 13 Composites (excl.Outdoor High Performance) 11 29 5 13 Outdoor High Performance Applications (7) (20) (4) (10) Growth in Asia / LATAM 10 51 3 11 Other 57 115 9 12 Sub-total 1,275$ 5,170$ 152$ 512$ Wage Inflation and Overtime (12) (18) Other Supply Chain Costs (4) (7) FX Impact (25) (70) (4) (8) Synergies 4 15 Travel, Other Employee Costs (1) (4) 2022 - Estimated 1,250$ 5,100$ 135$ 490$ Adjusted 2022 SALES AND OI – Q1 AND FULL YEAR 24 ($ millions) 2021 2022E Cash Flow from Operating Activities 234$ 385$ Less: Run-Rate CapEx (86) (90) CapEx for Clariant Integration (15) (20) CapEx for IT System Upgrade - (25) Total CapEx (101) (135) Free Cash Flow 133$ 250$ Adjusted EBITDA 581$ 635$ Net Debt / Adjusted EBITDA 2.2x 1.8x 25 CASH FLOW / LEVERAGE 26 • Record results – highest level of sales ($4.8B) and earnings ($3.05 adjusted EPS) in company history • Successful Clariant Color integration – net debt to adjusted EBITDA reduced to 2.2x, one-year ahead of schedule • Recognized as one of America’s Most Responsible Companies by Newsweek • Earned 3rd consecutive Great Place to Work certification 2021 HIGHLIGHTS 27 • 15% adjusted EPS growth to $3.50, led by growth in sustainable solutions and increased synergy realization • Continued strong synergy capture from the Clariant Color integration: $75M anticipated run-rate synergies by the end of 2022 • Adjusted EBITDA of $635M represents 9% growth above 2021 – 11% excluding the impact of foreign currencies • Deleveraged to 1.8x net debt to adjusted EBITDA by the end of 2022 2022 SUMMARY PEER COMPARISONS 29 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.

It’s in this spirit that we joined legacy PolyOne and the Clariant Masterbatch business, two complementary businesses, and formed a new one that we’ve named Avient. As one, we are better positioned than ever before to lead and to make a positive difference. D is t. ) LB Median: 5%Median: 3% Avient reflects 2021 estimated revenue of $4,100M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Other Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.

The company noted that GAAP EPS includes special items of $0.29 (Attachment 3) primarily associated with one-time tax benefits of $0.35, which was partially offset by acquisition-related and restructuring costs. In addition, a recording of the audio will be available for one week, beginning at 12:00 p.m. 2) Tax adjustments include the net tax benefit/(expense) from one-time income tax items, adjustments to uncertain tax position reserves and deferred income tax valuation allowances. 8 Attachment 4 Condensed Consolidated Balance Sheets (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 649.5 $ 864.7 Accounts receivable, net 516.6 330.0 Inventories, net 327.5 260.9 Other current assets 89.9 57.7 Total current assets 1,583.5 1,513.3 Property, net 694.9 407.4 Goodwill 1,308.1 685.7 Intangible assets, net 1,008.5 469.3 Operating lease assets, net 80.9 63.8 Other non-current assets 195.4 133.8 Total assets $ 4,871.3 $ 3,273.3 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 18.6 $ 18.4 Accounts payable 471.7 287.7 Current operating lease obligations 25.1 21.0 Accrued expenses and other current liabilities 289.2 375.4 Total current liabilities 804.6 702.5 Non-current liabilities: Long-term debt 1,854.0 1,210.9 Pension and other post-retirement benefits 115.0 56.6 Deferred income taxes 150.7 63.5 Non-current operating lease obligations 56.0 42.8 Other non-current liabilities 192.8 144.3 Total non-current liabilities 2,368.5 1,518.1 SHAREHOLDERS' EQUITY Avient shareholders’ equity 1,683.6 1,051.9 Noncontrolling interest 14.6 0.8 Total equity 1,698.2 1,052.7 Total liabilities and equity $ 4,871.3 $ 3,273.3 9 Attachment 5 Condensed Consolidated Statements of Cash Flows (Unaudited) Year Ended 2020 2019 Operating activities Net income $ 133.4 $ 588.8 Adjustments to reconcile net income to net cash provided by operating activities: Gain on sale of business, net of tax — (457.7) Depreciation and amortization 111.8 87.5 Accelerated depreciation and fixed asset charges associated with restructuring activities 3.2 — Deferred income tax benefit (1.1) (3.2) Share-based compensation expense 11.3 11.6 Changes in assets and liabilities, net of the effect of acquisitions: (Increase) decrease in accounts receivable (4.6) 29.7 Decrease in inventories 40.2 40.2 Increase (decrease) in accounts payable 79.5 (22.7) Increase (decrease) in pension and other post-retirement benefits 30.7 (19.7) Increase in post-acquisition earnout liabilities 1.0 36.4 (Decrease) increase in accrued expenses and other assets and liabilities - net (3.7) 9.9 Taxes paid on gain on sale of business (142.0) — Payment of post-acquisition date earnout liability (38.1) — Net cash provided by operating activities 221.6 300.8 Investing activities Capital expenditures (63.7) (81.7) Business acquisitions, net of cash acquired (1,380.2) (119.6) Net proceeds from divestiture 7.1 761.8 Net proceeds from other assets 5.2 51.4 Net cash (used) provided by investing activities (1,431.6) 611.9 Financing activities Debt offering proceeds 650.0 — Borrowings under credit facilities — 963.4 Repayments under credit facilities — (1,083.9) Purchase of common shares for treasury (22.4) (26.9) Cash dividends paid (71.3) (60.3) Repayment of other debt — (1.8) Repayment of long-term debt (7.8) (6.5) Payments on withholding tax on share awards (2.3) (2.1) Debt financing costs (9.5) (0.2) Equity offering proceeds, net of underwriting discount and issuance costs 496.1 — Payment of acquisition date earnout liability (50.8) — Net cash provided (used) by financing activities 982.0 (218.3) Effect of exchange rate changes on cash 12.8 (0.6) (Decrease) increase in cash and cash equivalents (215.2) 693.8 Cash and cash equivalents at beginning of year 864.7 170.9 Cash and cash equivalents at end of year $ 649.5 $ 864.7 10 Attachment 6 Business Segment Operations (Unaudited) Operating income at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

The company maintains its previously communicated full-year adjusted EPS guidance of $3.00, which is an increase of 55% over the prior year adjusted EPS of $1.93. 2 "This has been one of the most challenging years we have experienced as a result of navigating the COVID pandemic and an unprecedented combination of inflation, supply chain disruptions, and labor shortages,” Mr. In addition, a recording of the audio will be available for one week, beginning at 11:00 a.m. 2) Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) September 30, 2021 December 31, 2020 ASSETS Current assets: Cash and cash equivalents $ 545.2 $ 649.5 Accounts receivable, net 703.0 516.6 Inventories, net 477.2 327.5 Other current assets 123.5 108.5 Total current assets 1,848.9 1,602.1 Property, net 669.6 694.9 Goodwill 1,293.9 1,308.1 Intangible assets, net 948.4 1,008.5 Operating lease assets, net 81.6 80.9 Other non-current assets 168.6 176.0 Total assets $ 5,011.0 $ 4,870.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 8.7 $ 18.6 Accounts payable 557.7 471.7 Current operating lease obligations 24.1 25.1 Accrued expenses and other current liabilities 371.3 285.6 Total current liabilities 961.8 801.0 Non-current liabilities: Long-term debt 1,851.0 1,854.0 Pension and other post-retirement benefits 111.0 115.0 Non-current operating lease obligations 57.7 56.0 Other non-current liabilities 244.1 332.8 Total non-current liabilities 2,263.8 2,357.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 1,768.8 1,697.1 Noncontrolling interest 16.6 14.6 Total equity 1,785.4 1,711.7 Total liabilities and equity $ 5,011.0 $ 4,870.5 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Nine Months Ended September 30, 2021 2020 Operating Activities Net income $ 201.7 $ 58.6 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 105.8 74.8 Accelerated depreciation and amortization 1.9 2.5 Share-based compensation expense 8.4 7.1 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (199.7) (12.7) (Increase) decrease in inventories (156.2) 53.0 Increase in accounts payable 95.3 21.3 Decrease in pension and other post-retirement benefits (14.2) (14.4) Increase in post-acquisition earnout liabilities — 2.5 Increase in accrued expenses and other assets and liabilities, net 67.0 56.1 Taxes paid on gain on divestiture — (142.0) Payment of post-acquisition date earnout liability — (38.1) Net cash provided by operating activities 110.0 68.7 Investing activities Capital expenditures (62.7) (38.6) Business acquisitions, net of cash acquired (47.6) (1,342.7) Net proceeds from divestiture — 7.1 Other investing activities (2.0) 5.2 Net cash used by investing activities (112.3) (1,369.0) Financing activities Debt offering proceeds — 650.0 Purchase of common shares for treasury (4.2) (13.6) Cash dividends paid (58.2) (52.8) Repayment of long-term debt (16.5) (6.0) Payments of withholding tax on share awards (9.1) (1.9) Debt financing costs — (9.5) Equity offering proceeds, net of underwriting discount and issuance costs — 496.1 Payment of acquisition date earnout liability — (50.8) Other financing activities (3.5) — Net cash (used) provided by financing activities (91.5) 1,011.5 Effect of exchange rate changes on cash (10.5) 1.4 Decrease in cash and cash equivalents (104.3) (287.4) Cash and cash equivalents at beginning of year 649.5 864.7 Cash and cash equivalents at end of period $ 545.2 $ 577.3 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Specially formulated for both spunbond and meltblown manufacturing processes, they have no visible influence on color and can be customized to combine water repellency and color into one product for added convenience.

In order to ensure we can meet the established timelines for North America and Europe implementation of GHS, we started converting our systems about one year early. If you have specific questions on documents you have received from PolyOne, please contact your PolyOne seller or Customer Service Representative, who can put you in touch with one of our Product Stewardship representatives to help explain the change.

Thus, one of the limitations for most of the existing TPE overmolding technology is that one needs to develop and use different TPE materials for different substrates.

At least one member of the Audit Committee shall be an “audit committee financial expert” as defined by the Commission. Obtain and review a report from the independent auditor at least annually: (a) regarding the independent auditor’s internal quality-control procedures; (b) regarding any material issues raised by the most recent internal quality-control review, peer review or Public Company Accounting Oversight Board review of the firm, or by any inquiry or investigation by any other governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm; and any steps taken to address any such issues; and (c) to assess the auditor’s independence and all relationships between the independent auditor and the Company. 2.

lang=En&n=FD9B0E51-1 https://ec.ss.ec.gc.ca/auth/en/Services General Information Substance List CAS RN Substance Name Releases Releases (Speciated VOCs) Disposals Recycling Unit NA ­ 01 Antimony (and its compounds) 0.0004 N/A N/A N/A tonnes NA ­ 02 Arsenic (and its compounds) 0.0007 N/A N/A N/A kg 103­23­1 Bis(2­ethylhexyl) adipate 0.0106 N/A N/A N/A tonnes 117­81­7 Bis(2­ethylhexyl) phthalate 0.0283 N/A N/A N/A tonnes 85­68­7 Butyl benzyl phthalate 0.0008 N/A N/A N/A tonnes NA ­ 14 Zinc (and its compounds) 0.0000 N/A N/A 0.0002 tonnes Applicable Programs CAS RN Substance Name NPRI ON MOE TRA ON MOE Reg 127/01 First report for  this substance to  the ON MOE TRA NA ­ 01 Antimony (and its compounds) Yes NA ­ 02 Arsenic (and its compounds) Yes 103­23­1 Bis(2­ethylhexyl) adipate Yes 117­81­7 Bis(2­ethylhexyl) phthalate Yes 85­68­7 Butyl benzyl phthalate Yes NA ­ 14 Zinc (and its compounds) Yes Position: EHS Manager Telephone: 5192150535 Email: brian.greer@polyone.com Contact Type Certifying Official Name: Najat Kamal Position: EHSQ specialist Telephone: 5148089920 Email: najat.kamal@polyone.com Number of employees: 45 Activities for Which the 20,000­Hour Employee Threshold Does Not Apply: None of the above Activities Relevant to Reporting Dioxins, Furans and Hexacholorobenzene: None of the above Activities Relevant to Reporting of Polycyclic Aromatic Hydrocarbons (PAHs): Wood preservation using creosote: No Is this the first time the facility is reporting to the NPRI (under current or past ownership): Is the facility controlled by another Canadian company or companies: Did the facility report under other environmental regulations or permits: Is the facility required to report one or more NPRI Part 4 substances (Criteria Air Contaminants): Was the facility shut down for more than one week during the year: Operating Schedule ­ Days of the Week: Mon, Tue, Wed, Thu, Fri Usual Number of Operating Hours per day: 24 Usual Daily Start Time (24h) (hh:mm): 00:00 General Information about the Substance ­ Releases and Transfers of the Substance CAS RN Substance Name Was the substance released on­site The substance will be reported as the sum of releases to all media (total of 1 tonne or less) 1 tonne or more of a Part 5 Substance (Speciated VOC) was released to air Antimony (and its compounds) NA ­ 02 Arsenic (and its 103­23­1 Bis(2­ethylhexyl) adipate 117­81­7 Bis(2­ethylhexyl) 85­68­7 Butyl benzyl NA ­ 14 Zinc (and its General Information about the Substance ­ Disposals and Off­site Transfers for Recycling CAS RN Substance Name Was the substance disposed of (on­site or off­ site), or transferred for treatment prior to final disposal Is the facility required to report on disposals of tailings and waste rock for the selected reporting period Was the substance transferred off­site for recycling Antimony (and its NA ­ 02 Arsenic (and its 103­23­1 Bis(2­ ethylhexyl) adipate 117­81­7 Bis(2­ ethylhexyl) 85­68­7 Butyl benzyl NA ­ 14 Zinc (and its General Information about the Substance ­ Nature of Activities CAS RN Substance Name Manufacture the Substance Process the Substance Otherwise Use of the Substance NA ­ 01 Antimony (and its compounds) For on­site use/processing As a reactant As a by­product NA ­ 02 Arsenic (and its compounds) For on­site use/processing As a reactant As a by­product 103­23­1 Bis(2­ethylhexyl) adipate For on­site use/processing As a reactant As a by­product 117­81­7 Bis(2­ethylhexyl) phthalate For on­site use/processing As a reactant As a by­product 85­68­7 Butyl benzyl phthalate For on­site use/processing As a reactant As a by­product NA ­ 14 Zinc (and its compounds) For on­site use/processing As a reactant As a by­product On­site Releases ­ Releases to air NA ­ 02 Arsenic (and its compounds) Stack or Point Releases O ­ Engineering Estimates 0.0000 kg NA ­ 14 Zinc (and its compounds) Stack or Point Releases O ­ Engineering Estimates 0.0000 tonnes On­site Releases ­ Releases to air ­ Total CAS RN Substance Name Total ­ Releases to Air NA ­ 02 Arsenic (and its compounds) 0.0000 kg NA ­ 14 Zinc (and its compounds) 0.0000 tonnes On­site Releases ­ Releases to land NA ­ 02 Arsenic (and its compounds) Other O ­ Engineering Estimates 0.0007 kg Onsite Releases ­ Nature of Other Land Release CAS RN Substance Name Nature of Other Land Release NA ­ 02 Arsenic (and its compounds) Landfill disposal CAS RN Substance Name Nature of Other Land Release On­site Releases ­ Releases to land ­ Total CAS RN Substance Name Total ­ Releases to Land NA ­ 02 Arsenic (and its compounds) 0.0007 kg Total Quantity Released (All Media) NA ­ 01 Antimony (and its compounds) Total Quantity Released O ­ Engineering Estimates 0.0004 tonnes 103­23­1 Bis(2­ethylhexyl) adipate Total Quantity Released O ­ Engineering Estimates 0.0106 tonnes 117­81­7 Bis(2­ethylhexyl) phthalate Total Quantity Released O ­ Engineering Estimates 0.0283 tonnes 85­68­7 Butyl benzyl phthalate Total Quantity Released O ­ Engineering Estimates 0.0008 tonnes On­site Releases ­ Total CAS RN Substance Name Total releases NA ­ 02 Arsenic (and its compounds) 0.0007 kg NA ­ 14 Zinc (and its compounds) 0.0000 tonnes On­site Releases ­ Quarterly Breakdown of Annual Releases CAS RN Substance Name Quarter 1 Quarter 2 Quarter 3 Quarter 4 NA ­ 01 Antimony (and its compounds) 25 25 25 25 NA ­ 02 Arsenic (and its compounds) 25 25 25 25 103­23­1 Bis(2­ethylhexyl) adipate 25 25 25 25 117­81­7 Bis(2­ethylhexyl) phthalate 25 25 25 25 85­68­7 Butyl benzyl phthalate 25 25 25 25 On­site Releases ­ Reasons for Changes in Quantities Released from Previous Year CAS RN Substance Name Reasons for Changes in Quantities from Previous Year Comments NA ­ 01 Antimony (and its compounds) No significant change (i.e. 

As gases may also be delivered into the system by direct injection (then called physical blowing agents), one needs to differentiate between the physical blowing agents (PFAs) and chemical foaming agents (CFAs). Once the cavity is filled, the mold opens, or one of the sides has a slide, to allow the expansion of the gas-loaded compound.